Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM) Shares Down 6.6% – Here’s Why

Zomedica Pharmaceuticals Corp. (ZOM.V) (CVE:ZOM)’s share price dropped 6.6% during trading on Monday . The company traded as low as C$0.29 and last traded at C$0.29. Approximately 4,800 shares were traded during trading, an increase of 68% from the average daily volume of 2,858 shares. The stock had previously closed at C$0.31.

Zomedica Pharmaceuticals Corp. (ZOM.V) Trading Down 6.6 %

The company has a debt-to-equity ratio of 4.91, a current ratio of 15.31 and a quick ratio of 15.25. The business has a 50-day simple moving average of C$0.29 and a two-hundred day simple moving average of C$0.28. The stock has a market cap of C$36.73 million and a price-to-earnings ratio of -2.61.

Zomedica Pharmaceuticals Corp. (ZOM.V) Company Profile

Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies.